PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
900 participants
May 21, 2024
OBSERVATIONAL
Conditions
Summary
This is a prospective cohort study, where the investigators aim to investigate the effect of implementation of an electronic nudge alerting clinicians to the prescription of the 4 key pharmacological classes for the treatment of patients with heart failure and reduced ejection fraction (HFrEF) at the outpatient clinic in the Netherlands.
Eligibility
Inclusion Criteria3
- Age \> 18 years
- Treatment for HFrEF at the outpatient clinic cardiology.
- Documented reduced ejection fraction of \<40% based on cardiac ultrasound or cardiac magnetic resonance imaging.
Exclusion Criteria1
- Opt-out for the use of routine clinical data for research purposes
Interventions
An algorithm will check if the patients if the patient has an age \>18 year and is treated at the cardiology department for HFrEF. The use of GDMT is determined using prescriptions data electronic health records (EHR). If the patient does not receive treatment for all 4 drug classes (ACE/ARB/ARNi, beta-blocker, MRA, SGLT2-inhibitor), an electronic alert will be displayed suggesting the clinician to prescribe additional medication when clinically indicated, including relevant recent laboratory results (renal function and electrolytes) and other relevant measures (LVEF, blood pressure and heart rate). The alert is linked to an order set to aid in the prescription of GDMT according to current guidelines. Results will compared to a retrospective cohort (t=-12 to t=-6) months, and a silent mode cohort (t=-6 to t=0 months, in which a paired and a before and after analysis will be performed to evaluate the effect of the alert.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06344910